Evidence map›Paper›PMID 41343758›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Noncomparative Comparisons: The Paradox of Randomized Noncomparative Trials.

Alexander D Sherry, Ethan B Ludmir, Pavlos Msaouel

Abstract readLetter
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander D SherryAlexander D. Sherry, MD, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Radiation Oncology, Mayo Clinic, Rochester, MN; Ethan B. Ludmir, MD, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; and Pavlos Msaouel, MD, PhD, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-5115-1691
Ethan B LudmirAlexander D. Sherry, MD, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Radiation Oncology, Mayo Clinic, Rochester, MN; Ethan B. Ludmir, MD, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; and Pavlos Msaouel, MD, PhD, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-5472-5344
Pavlos MsaouelAlexander D. Sherry, MD, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Radiation Oncology, Mayo Clinic, Rochester, MN; Ethan B. Ludmir, MD, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; and Pavlos Msaouel, MD, PhD, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-6505-8308

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41343758
PMCPMC13152004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.